Financials in USD. Standardized financial statements.
A compact view of how Synovics Pharmaceuticals, Inc. turns revenue into operating income and net income.
| Metric | FY 2008 | FY 2007 | FY 2006 | FY 2005 | FY 2004 | FY 2003 | FY 2002 | FY 2001 | FY 2000 | FY 1999 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $25.96M | $23.47M | $10.52M | $8,192 | $98,767 | $31,978 | $36,516 | $37,630 | $134,079 | $3.13M |
| Revenue Growth? | +10.6% | +123.1% | +128274.0% | -91.7% | +208.9% | -12.4% | -3.0% | -71.9% | -95.7% | 0.0% |
| Cost of Revenue? | $16.99M | $16.84M | $8.16M | $45,289 | $18,269 | $5,829 | $14,182 | $59,746 | $165,042 | $2.33M |
| Gross Profit? | $8.97M | $6.63M | $2.36M | -$37,097 | $80,498 | $26,149 | $22,334 | -$22,116 | -$30,963 | $796,646 |
| Gross Margin? | +34.6% | +28.2% | +22.4% | -452.8% | +81.5% | +81.8% | +61.2% | -58.8% | -23.1% | +25.4% |
| Operating Expenses? | $11.45M | $16.89M | $5.98M | $1.87M | $866,913 | $468,418 | $1.25M | $2.46M | $2.95M | $6.31M |
| Operating Income? | -$2.48M | -$10.26M | -$3.62M | -$1.91M | -$786,415 | -$442,269 | -$1.22M | -$2.49M | -$2.98M | -$5.51M |
| EBITDA? | -$1.87M | -$10.26M | -$2.27M | -$1.84M | -$755,535 | -$412,684 | -$1.19M | -$2.45M | -$2.88M | -$4.39M |
| Income Before Tax | -$4.01M | -$20.86M | -$7.53M | -$2.69M | -$1.12M | -$759,522 | -$1.84M | $0 | $0 | $0 |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income? | -$4.01M | -$20.86M | -$8.57M | -$2.91M | -$1.12M | -$759,522 | -$1.84M | -$2.89M | -$3.15M | -$5.62M |
| EPS? | $-0.17 | $-1.09 | $-0.33 | $-0.14 | $-0.14 | $-0.17 | $-0.42 | $-0.64 | $-0.75 | $-1.35 |
| Diluted EPS? | $-0.17 | $-1.09 | $-0.33 | $-0.14 | $-0.14 | $-0.17 | $-0.42 | $-0.64 | $-0.75 | $-1.35 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality